Drug intelligence / Profile preview

Olive

Development stage
Unknown
Lead developer
Oleolive
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Olive refers to products derived from the olive tree (Olea europaea), primarily olive oil and olive leaf tea, which are studied for their various health benefits. Olive oil, particularly extra virgin olive oil, is rich in monounsaturated fatty acids (MUFAs) like oleic acid, and phenolic compounds such as oleocanthal and oleuropein. These components are associated with anti-inflammatory, antioxidant, and immunomodulatory properties. Olive oil is often incorporated into dietary patterns like the Mediterranean diet and has been investigated for its effects on cardiovascular health, lipid profiles, insulin sensitivity, and cognitive function. Olive leaf tea, also rich in polyphenols, is studied for its immunomodulatory, anti-inflammatory, antioxidant, hypoglycemic, antihypertensive, antimicrobial, and anti-atherosclerotic effects. These products are considered dietary supplements or nutraceuticals due to their nutritional value and potential therapeutic applications.

02

Targets

ALOX12 (Arachidonate 12-lipoxygenase, 12S type)AMPK (Adenosine monophosphate–activated protein kinase)COXPLA2 (Phospholipase A2 group IID)LRP1 (Prolow-density lipoprotein receptor-related protein 1)

Beyond the preview

Go deeper on Olive.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olive.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call